Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

SSK1

Cat. No.: IBDI-432755

SSK1, a senescence-specific killing compound, is a β-galactosidase-targeted proagent attenuates inflammation. SSK1 is activated by lysosomal β-galactosidase and selectively killed senescent cells through the activation of p38 MAPK and induction of apoptosis.

Size (Solid):

Product Details

Target p38 MAPK | Apoptosis
Molecular Weight 788.61
Appearance Solid
SMILES CC(O[[email protected]]([[email protected]]([[email protected]]1OC(C)=O)OC(C)=O)[[email protected]@H](O[[email protected]@H]1COC(C)=O)OC(C=CC(COC(NC(C=CN2[[email protected]](C(F)([[email protected]@H]3O)F)([H])O[[email protected]@H]3CO)=NC2=O)=O)=C4)=C4[N+]([O-])=O)=O
Purity 99.19%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.